Marchex (Nasdaq: MCHX ) is expected to report Q2 earnings around July 12. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Marchex's revenues will increase 6.4% and EPS will compress -50.0%.
The average estimate for revenue is $36.2 million. On the bottom line, the average EPS estimate is $0.03.
Last quarter, Marchex booked revenue of $36.2 million. GAAP reported sales were 2.1% higher than the prior-year quarter's $35.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.04. GAAP EPS shrank to zero from the prior-year quarter's -$0.02.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 40.9%, 250 basis points worse than the prior-year quarter. Operating margin was -2.1%, 410 basis points better than the prior-year quarter. Net margin was 0.2%, 220 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $146.5 million. The average EPS estimate is $0.19.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 110 members out of 129 rating the stock outperform, and 19 members rating it underperform. Among 38 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give Marchex a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Marchex is outperform, with an average price target of $6.00.
Internet software and services are being consumed in radically different ways, on new and increasingly mobile devices. Is Marchex on the right side of the revolution? Check out the changing landscape and meet the company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Marchex to My Watchlist.